MedPath

3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia

Not Applicable
Completed
Conditions
Recurrent
Hematoma
Chronic Pain
Infections
Seroma
Inguinal Hernia
Registration Number
NCT06314152
Lead Sponsor
Nanchong Central Hospital
Brief Summary

This study was designed to compare the outcome of 3 point with 1 point lightweight mesh fixation in TAPP surgery for patients with inguinal hernia. The main outcome include seroma, chronic pain, recurrence, et al.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
351
Inclusion Criteria
  • Unilateral inguinal hernia according to preoperative physical examination and imaging examination.

The inclusion criteria were as follows: primary indirect inguinal hernia.

Exclusion Criteria
  • Age below 18 years or older than 80. recurrent hernia, incarcerated hernia, direct hernia, strangulated hernia, and other types of hernias.

Patients not suitable for general anesthesia. Patients requiring open surgery; patients requiring emergency surgery Loss to follow-up or communication difficulties, or poor compliance.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of postoperative pain6 months

The visual analog scale (VAS) was adopted for pain evaluation 2 days, 3 months, and 6 months postoperatively. The scale range from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain.

Rate of recurrence1 month,3 months,6 months and 12 months after surgery

Hernia recurrenceFollow up by physical examination, ultrasonography and telephone at 1 month,3 months,6 months and 12 months after surgery about the rate of hernia recurrence.

Secondary Outcome Measures
NameTimeMethod
Rate of postoperative complications6 months

Including infection, seroma, hematoma

Trial Locations

Locations (1)

Yunhong Tian

🇨🇳

Nanchong, Sichuan, China

Yunhong Tian
🇨🇳Nanchong, Sichuan, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.